OPTN(Delisted)
OptiNoseยทNASDAQ
--
--(--)
OPTN Profile
Optinose, Inc.
A pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists
1020 Stony Hill Road, Suite 300, Yardley, Pennsylvania 19067
--
OptiNose, Inc. Incorporated in Delaware in May 2010. The company is a professional pharmaceutical company focused on product development and commercialization for otolaryngology, or ENT patients, and professional treatment of allergies. The company's main product, XHANCE (flutisone) nasal spray, utilizes a unique respiratory exhalation system, or EDS, to provide one of the most effective anti-inflammatory corticosteroids for the treatment of chronic sinusitis and nasal polyps.
